Viewing Study NCT04365868

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2026-05-24 @ 2:22 PM
Study NCT ID: NCT04365868
Status: TERMINATED
Last Update Posted: 2025-12-15
First Post: 2020-04-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
Sponsor: Galectin Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prevention of Esophageal Varices View
None NASH - Nonalcoholic Steatohepatitis View
None Cirrhosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None esophageal varices View
None belapectin View
None GR-MD-02 View
None portal hypertension View
None nonalcoholic steatohepatitis (NASH) cirrhosis View
None NASH View
None cirrhosis View